Critique of DSM-IV: associated features of neuroleptic-induced parkinsonism.
Segraves
T
T
Abdel-Dayem
M
M
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001767:Blinking; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000145:classification / Q000175:diagnosis*; D011569:Psychiatric Status Rating Scales; D012021:Reflex, Abnormal; D009626:Terminology as Topic
D014150:Antipsychotic Agents